Provectus Biopharmaceuticals Inc (PVCT)

OTC Markets

Currency in USD

0.09000

+0.00500(+5.88%)

Closed·26/08

Fair Value

Unlock Value

Day's Range

0.08305

0.09000

52 wk Range

0.06610

0.15166

PVCT Financial Summary

A brief financial summary of Provectus Biopharmaceuticals Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio-5.82

Price/Book-6.3

Debt / Equity-42.8%

Return on Equity95.98%

Dividend Yield0.00%

EBITDA-3.94M

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

0.99

0.56

0.62

Gross Profit

aa.aa

-2.52

-1.32

-1.14

-1.34

Operating Income

aa.aa

-4.94

-4.64

-2.87

-2.5

-3.95

Net Income

aa.aa

-6.68

-5.54

-3.55

-3.1

-4.76

Balance Sheet

Total Assets

aa.aa

0.59

3.51

2.04

1.45

1.01

Total Current Liabilities

aa.aa

30.71

7.7

8.19

9.02

6.98

Total Equity

aa.aa

-30.21

-4.19

-6.23

-7.59

-5.97

Cash Flow

Levered Free Cash Flow

aa.aa

1.06

-6.94

-0.88

-1.16

-2.93

Cash from Operations

aa.aa

-4.09

-1.01

-3.04

-2.57

-3.28

Cash from Investing

aa.aa

Cash from Financing

aa.aa

3.6

4.02

1.37

2.19

2.75

Net Change in Cash

aa.aa

-0.49

3.01

-1.68

-0.4

-0.54

* In Millions of USD (except for per share items)

Earnings

Latest Release

Aug 14, 2025

EPS / Forecast

-- / --

Revenue / Forecast

57.48K / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Provectus's earnings for the latest quarter?

The Provectus EPS (TTM) is -0.02. Provectus reported sales of 0.06, net income of -1.81, and EPS of 0.00 for the latest quarter.

What was Provectus's net income for the latest quarter?

Provectus's net income for the latest quarter was -1.81.

How did Provectus's performance compare year-over-year in the latest quarter?

The company's revenue moved from 0.28 in the previous quarter to 0.06 in the latest quarter, and net income moved from -1.14 to -1.81 compared to the previous quarter.

What is Provectus's net profit margin on a TTM basis?

Provectus's trailing twelve months (TTM) net profit margin is -771.65%.

How does Provectus's debt to equity ratio compare to industry standards?

Provectus's total debt-to-equity ratio is -42.80%.

What is Provectus's return on investment on a TTM basis?

Provectus's trailing twelve months (TTM) return on investment (ROI) is 95.98%.

Did Provectus gain or lose cash last quarter?

In the latest quarter, Provectus's net change in cash was -0.05 million.

What were Provectus's total assets and liabilities in the latest quarter?

As of the latest quarter, Provectus reported total assets of 0.72 million and total liabilities of 6.49 million.

How has Provectus's total revenue grown this year?

Provectus's total revenue was 0.28 in the previous quarter and 0.06 in the latest quarter.

What is Provectus's gross margin on a TTM basis?

Provectus's trailing twelve months (TTM) gross margin is -376.58%.

What was Provectus's revenue per share for the latest quarter?

Provectus's revenue per share for the latest quarter was 3.07.

NSE 30

5,166.25

+13.26

+0.26%

NSE All Share

141,761.36

+321.61

+0.23%

US 30

45,409.00

-9.1

-0.02%

US 500

6,464.40

-1.5

-0.02%

FTSE 100

9,280.85

+15.05

+0.16%

DAX

24,157.47

-22.40

-0.09%

South Africa Top 40

94,382.43

-364.65

-0.38%

Market Movers

Name	Last	Chg. %	Vol.
Fcmb	11.200	+2.75%	89.30M
Access Holdings	27.50	+0.18%	21.44M
Lafarge Africa	134.00	-0.41%	12.15M
Guaranty Trust Holding	98.00	+2.03%	12.07M
Zenith Bank	70.60	+0.86%	8.65M
MTN Nigeria	435.00	0.00%	3.54M
Aradel Holdings	510.00	0.00%	996.87K

Name	Last	Chg. %	Vol.
Ncr Nigeria	11.55	+10.00%	138.49K
Skye Shelter Fund	301.55	+9.99%	210.67K
Berger Paints	34.90	+9.06%	1.03M
Betaglas	486.00	+8.16%	238.73K
Cadbury Nig	62.50	+8.04%	1.49M
Sovereign Trust Insurance Plc	2.85	+7.55%	5.87M
Chams	3.09	+6.92%	20.69M

Name	Last	Chg. %	Vol.
Secure Electronic Tech	0.98	-9.26%	27.30M
Cutix	3.550	-8.97%	8.80M
UAC Of Nigeria	73.00	-8.69%	1.37M
Deap Capital Management Trust	1.66	-8.29%	3.18M
Guinea Insurance PLC	1.60	-8.05%	8.33M
FTN Cocoa Processors PLC	6.49	-7.29%	4.97M
ETI	36.50	-6.89%	6.04M

Trending Stocks

Name	Last	Chg. %	Vol.
Ellah Lakes	15.30	-3.16%	9.41M
Guaranty Trust Holding	98.00	+2.03%	12.07M
MTN Nigeria	435.00	0.00%	3.54M
Cutix	3.550	-8.97%	8.80M
Aiico	4.43	-0.89%	36.15M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaa Aaaaaa	5,379.30	+45.20%	7,810.74
Aa Aa Aaaa Aaaa	520.00	+36.56%	710.11
Aaaaaaaaaaa Aa	151.80	+33.37%	202.46
Aaaaaaaaa Aaa Aaaaa	1,890.00	+30.71%	2,470.42
Aaaaaa	640.00	+22.16%	781.82
Aaaaaaaa A	70.20	+18.47%	83.17

Name	Last	Upside	Fair Value
Aaaaaaaaaa Aaaaaa	5,379.30	+45.20%	7,810.74
Aa Aa Aaaa Aaaa	520.00	+36.56%	710.11
Aaaaaaaaaaa Aa	151.80	+33.37%	202.46
Aaaaaaaaa Aaa Aaaaa	1,890.00	+30.71%	2,470.42
Aaaaaa	640.00	+22.16%	781.82
Aaaaaaaa A	70.20	+18.47%	83.17

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Provectus Biopharmaceuticals Inc (PVCT)

PVCT Financial Summary

Key Ratios

Statements Highlights

Earnings

FAQ

What were Provectus's earnings for the latest quarter?

What was Provectus's net income for the latest quarter?

How did Provectus's performance compare year-over-year in the latest quarter?

What is Provectus's net profit margin on a TTM basis?

How does Provectus's debt to equity ratio compare to industry standards?

What is Provectus's return on investment on a TTM basis?

Did Provectus gain or lose cash last quarter?

What were Provectus's total assets and liabilities in the latest quarter?

How has Provectus's total revenue grown this year?

What is Provectus's gross margin on a TTM basis?

What was Provectus's revenue per share for the latest quarter?

Trending Stocks